BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 20932471)

  • 1. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.
    Abbas T; Shibata E; Park J; Jha S; Karnani N; Dutta A
    Mol Cell; 2010 Oct; 40(1):9-21. PubMed ID: 20932471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase.
    Centore RC; Havens CG; Manning AL; Li JM; Flynn RL; Tse A; Jin J; Dyson NJ; Walter JC; Zou L
    Mol Cell; 2010 Oct; 40(1):22-33. PubMed ID: 20932472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage.
    Oda H; Hübner MR; Beck DB; Vermeulen M; Hurwitz J; Spector DL; Reinberg D
    Mol Cell; 2010 Nov; 40(3):364-76. PubMed ID: 21035370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation.
    Jørgensen S; Eskildsen M; Fugger K; Hansen L; Larsen MS; Kousholt AN; Syljuåsen RG; Trelle MB; Jensen ON; Helin K; Sørensen CS
    J Cell Biol; 2011 Jan; 192(1):43-54. PubMed ID: 21220508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.
    Benamar M; Guessous F; Du K; Corbett P; Obeid J; Gioeli D; Slingluff CL; Abbas T
    EBioMedicine; 2016 Aug; 10():85-100. PubMed ID: 27333051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK1-dependent inhibition of the E3 ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis.
    Rizzardi LF; Coleman KE; Varma D; Matson JP; Oh S; Cook JG
    J Biol Chem; 2015 Jan; 290(1):556-67. PubMed ID: 25411249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration.
    Abbas T; Mueller AC; Shibata E; Keaton M; Rossi M; Dutta A
    Mol Cell; 2013 Mar; 49(6):1147-58. PubMed ID: 23478445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2.
    Abbas T; Keaton M; Dutta A
    Cell Cycle; 2013 Jul; 12(14):2175-82. PubMed ID: 23892434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.
    Shibata E; Abbas T; Huang X; Wohlschlegel JA; Dutta A
    Mol Cell Biol; 2011 Aug; 31(15):3136-45. PubMed ID: 21628527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRL4(CDT2) targets CHK1 for PCNA-independent destruction.
    Huh J; Piwnica-Worms H
    Mol Cell Biol; 2013 Jan; 33(2):213-26. PubMed ID: 23109433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRL4Cdt2 E3 ubiquitin ligase and proliferating cell nuclear antigen (PCNA) cooperate to degrade thymine DNA glycosylase in S phase.
    Shibata E; Dar A; Dutta A
    J Biol Chem; 2014 Aug; 289(33):23056-23064. PubMed ID: 24962565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-cycle regulation of non-enzymatic functions of the Drosophila methyltransferase PR-Set7.
    Zouaz A; Fernando C; Perez Y; Sardet C; Julien E; Grimaud C
    Nucleic Acids Res; 2018 Apr; 46(6):2834-2849. PubMed ID: 29373730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCF(β-TRCP) promotes cell growth by targeting PR-Set7/Set8 for degradation.
    Wang Z; Dai X; Zhong J; Inuzuka H; Wan L; Li X; Wang L; Ye X; Sun L; Gao D; Zou L; Wei W
    Nat Commun; 2015 Dec; 6():10185. PubMed ID: 26666832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone H4 lysine 20 monomethyl mark, set by PR-Set7 and stabilized by L(3)mbt, is necessary for proper interphase chromatin organization.
    Sakaguchi A; Joyce E; Aoki T; Schedl P; Steward R
    PLoS One; 2012; 7(9):e45321. PubMed ID: 23024815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of p53 function by SET8-mediated methylation at lysine 382.
    Shi X; Kachirskaia I; Yamaguchi H; West LE; Wen H; Wang EW; Dutta S; Appella E; Gozani O
    Mol Cell; 2007 Aug; 27(4):636-46. PubMed ID: 17707234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone methyltransferase SET8 is required for S-phase progression.
    Jørgensen S; Elvers I; Trelle MB; Menzel T; Eskildsen M; Jensen ON; Helleday T; Helin K; Sørensen CS
    J Cell Biol; 2007 Dec; 179(7):1337-45. PubMed ID: 18166648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle.
    Zheng N; Dai X; Wang Z; Wei W
    Cell Cycle; 2016 Nov; 15(22):3042-3047. PubMed ID: 27649746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PR-Set7 binding domain of Riz1 is required for the H4K20me1-H3K9me1 trans-tail 'histone code' and Riz1 tumor suppressor function.
    Congdon LM; Sims JK; Tuzon CT; Rice JC
    Nucleic Acids Res; 2014 Apr; 42(6):3580-9. PubMed ID: 24423864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRL4
    Mazian MA; Yamanishi K; Rahman MZA; Ganasen M; Nishitani H
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct interaction between SET8 and proliferating cell nuclear antigen couples H4-K20 methylation with DNA replication.
    Huen MS; Sy SM; van Deursen JM; Chen J
    J Biol Chem; 2008 Apr; 283(17):11073-7. PubMed ID: 18319261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.